Viewing StudyNCT00519324



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00519324
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2007-08-21

Brief Title: Efficacy and Safety of Everolimus RAD001 in Patients With Advanced Gastric Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Advanced Gastric Cancer
Keywords:
Name View
mTOR View
Gastric Cancer View
RAD001 View